이인호 차관 “지재권 보유한 바이오 스타트업에 R&D 지원 확대”

글 내용 전체보기

Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke

글 내용 전체보기

Agios crowns Celgene veteran Jackie Fouse CEO to spearhead leukemia drug launches

글 내용 전체보기

Post-Monsanto deal, Bayer pharma holds its own as consumer health continues its slide

글 내용 전체보기

Juno investors eke out $24M settlement in lawsuit over CAR-T trial deaths

글 내용 전체보기

Eli Lilly, Chi-Med’s Elunate becomes first China-made cancer drug to win a key nod

글 내용 전체보기

After snubbing Gilead, British cost watchdogs give thumbs-up to Novartis’ CAR-T Kymriah

글 내용 전체보기

No sweat? Dermira snags reps, sets price and plots branded ads for Qbrexza launch

글 내용 전체보기

Otsuka’s dose-tracking digital pill charts its first course to market with Magellan

글 내용 전체보기

Novo Nordisk’s Ozempic spends big on TV in August but still trails AbbVie, Pfizer big guns

글 내용 전체보기

Italian CDMO buys India API plant that supplies Novartis

글 내용 전체보기

Sangamo slides on first genome-editing trial results

글 내용 전체보기

Startup Gossamer Bio poaches Bristol-Myers Squibb executive as CSO

글 내용 전체보기

Teva finally dumps laquinimod, ending failure-riddled saga

글 내용 전체보기

Biohaven picks up AstraZeneca CNS drug, plans phase 3

글 내용 전체보기

Ramaswamy loses another key executive as Fouse jumps ship to Agios

글 내용 전체보기

Fulcrum Therapeutics gets off $80M series B round

글 내용 전체보기

PhaseBio nets $34M to advance Brilinta reversal agent, PAH drug

글 내용 전체보기

Sean Harper and Beth Seidenberg unite to run $320M VC fund

글 내용 전체보기

With promising data, ProQR Therapeutics’ RNA-based eye drug heads to phase 3

글 내용 전체보기

A telephone for your microbiome

글 내용 전체보기